Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04281472 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease

NCT05662241 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies

NCT04153422 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

NCT06909214 ·Status: RECRUITING ·Phase: PHASE4

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

NCT03920293 ·Status: COMPLETED ·Phase: PHASE3

Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

NCT00004286 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

NCT05979441 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

IVIg for Demyelination in Diabetes Mellitus

NCT02372149 ·Status: UNKNOWN ·Phase: PHASE4

Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

NCT00588822 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

NCT01997229 ·Status: COMPLETED ·Phase: PHASE3

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

NCT07047690 ·Status: RECRUITING ·Phase: PHASE2

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

NCT04163419 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT00099489 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

NCT07020819 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome

NCT04701164 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis

NCT00348296 ·Status: COMPLETED ·Phase: PHASE3

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

NCT00106184 ·Status: COMPLETED ·Phase: PHASE2

Efgartigimod for the Treatment of Guillain-Barré Syndrome

NCT06885762 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)

NCT02774239 ·Status: COMPLETED ·Phase: PHASE3

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

NCT06698796 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis

NCT02473952 ·Status: COMPLETED ·Phase: PHASE2

Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome

NCT05701189 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

NCT05895786 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

NCT06284954 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT02549170 ·Status: COMPLETED ·Phase: PHASE3